Navigation Links
Telesso Technologies wins Popular Science Invention Award for its novel peripheral IV catheter
Date:5/13/2009

Telesso Technologies Limited (ASX: TEO), a global healthcare company, announced today the FDA-approved guide wire-assisted peripheral IV catheter it is developing with Vascular Pathways, Inc., has been honored with the Popular Science Invention Award.

"Telesso is pleased to receive another exciting external validation of this innovative device that may revolutionize peripheral IV placement," said Telesso's CEO Nelson K. Stacks. "Attempts to start an IV frequently fail, which is frustrating for clinicians, painful for patients and costly to the health care system. The new guide-wire assisted peripheral IV catheter uses a practical design to improve the ability for clinicians to get it right the first time, creating efficiency, enhancing safety, reducing costs, and avoiding the need for re-sticks."

A post-market trial is currently comparing patients treated with Telesso's catheter to the industry's gold standard device for peripheral IV placement. Data review is expected in Q2-Q3 2009.

About the Guide Wire-Assisted Peripheral IV Catheter

A peripheral vein is the most common site for insertion of a catheter for short-term diagnostic or therapeutic use. The catheter is placed into the peripheral vein in the arm and is typically passed up inside the vein to a length of 2-3 inches. Telesso's uniquely-designed guide wire-assisted peripheral IV catheter device uses a first-in-class retractable nitinol guide wire system that is believed to enable easier IV access, reduce common safety risks, significantly lessen patient pain and discomfort, and provide cost savings to facilities by lowering administrative costs associated with failed IV starts. Telesso believes this catheter device is the first clinically meaningful advancement in peripheral IV access since automatic needle retraction catheters and addresses significant unmet needs in peripheral intravenous access.


'/>"/>

Contact: Jeff Riley
riley@telesso.com
619-309-7661
Cytori Therapeutics
Source:Eurekalert

Page: 1

Related medicine news :

1. Telesso initiates post-market head-to-head peripheral IV catheter study
2. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
3. MedClean Technologies, Inc. Approved in New Jersey
4. The EntreTech Forum Presents ... PHOTONICS/OPTICS - Understanding the Latest Applications of Light-based Technologies in Medical, Consumer, Industrial, and Defense Sectors
5. Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund
6. Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results
7. Steven H. Kane Appointed as President and Chief Executive Officer of Patient Safety Technologies, Inc.
8. Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009
9. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
10. Greenway Medical Technologies PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care
11. Top 10 Hospital Technologies: C-Suite Watch List for 2009 and Beyond; Exclusive Insight on Critical Capital Decisions in ECRI Institute White Paper Available for Free Download
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
(Date:10/12/2017)... ... , ... In the United States, single-family home owners pay ... York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 a ... rates, which contributes to the relatively lower cost of living in places like ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: